Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials

Published:2017-03-14 Issue:4 Volume:176 Page:890-901
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Rungapiromnan W.¹,Yiu Z.Z.N.¹²,Warren R.B.²,Griffiths C.E.M.²,Ashcroft D.M.¹

Affiliation:

1. Centre for Pharmacoepidemiology and Drug Safety; Manchester Pharmacy School; University of Manchester; Manchester M13 9PT U.K.

2. Dermatology Centre; Salford Royal NHS Foundation Trust; University of Manchester; Manchester Academic Health Science Centre; Manchester U.K.

Funder

Royal Thai Government

National Institute for Health Research

Medical Research Council

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14964/fullpdf

Reference68 articles.

1. Risk of myocardial infarction in patients with psoriasis;Gelfand;JAMA,2006

2. Coronary artery disease in patients with psoriasis referred for coronary angiography;Armstrong;Am J Cardiol,2012

3. Psoriasis and hypertension severity: Results from a case-control study;Armstrong;PLOS One,2011

4. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis;Samarasekera;J Invest Dermatol,2013

5. Psoriasis and the risk of major cardiovascular events: cohort study using the Clinical Practice Research Datalink;Parisi;J Invest Dermatol,2015

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study;Archives of Dermatological Research;2024-09-11

2. Endothelial Dysfunction in Psoriasis: An Integrative Review;Journal of Investigative Dermatology;2024-09

3. Targeted therapy for immune mediated skin diseases. What should a dermatologist know?;Anais Brasileiros de Dermatologia;2024-07

4. Biologics for Psoriasis;Dermatologic Clinics;2024-07

5. The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2024-05-24